| Material Safety Data Sheet |
| Amoxyclav 50, 200, 250 and 500 Broadspectrum Antibiotic Tablets |
| Classified as hazardous according to the criteria of NOHSC |
SECTION I Identification of the Material and Supplier |
| Product Name |
Amoxyclav 50, 200, 250 and 500 Broadspectrum Antibiotic Tablets |
| Recommended Use |
|
| Supplier Details |
Apex Laboratories Pty. Ltd. |
| ACN Number |
000 397 240 |
| Street |
61 Chivers Road |
| Suburb |
Somersby |
| State |
NSW |
| Country |
Australia |
| Post Code |
2250 |
| Phone |
+61 2 4372 1661 (Business hours – 8.30am – 5.00pm) |
| Fax |
+61 2 4372 1668 (fax) |
| Website |
http://www.apexlabs.com.au |
| Emergency contact |
As above or Poisons Information Centre 131126 (Australia) |
SECTION II Hazard Identification |
| Classification |
Classified as hazardous according to the criteria of NOHSC |
| Risk Phrases |
R42/43 May cause sensitisation by inhalation and skin contact
|
| Safety Phrases |
None allocated |
| ADG Class |
None allocated |
| Hazchem Code |
None allocated |
| Poisons Schedule |
S4 |
SECTION III Composition |
| Ingredients |
CAS No |
Proportion |
TWA mg/m3 |
STEL mg/m3 |
| Amoxycillin |
61336-70-7 |
30-60% |
not set |
not set |
Clavulanic Acid |
61177-45-5 |
<10% |
not set |
not set |
Other non hazardous ingredients |
NA |
to 100% |
NA |
NA |
|
| The TWA exposure value is the average airborne concentration of a particular substance when calculated over a normal 8 hour working day for a 5 day working week over an entire working lifetime. The TWA exposure standard set by Worksafe Australia for dusts not otherwise specified is 10mg/m3. The STEL (Short Term Exposure Limit) is an exposure value that should not be exceeded for more than 15 minutes and should not be repeated for more than 4 times per day. There should be at least 60 minutes between successive exposures at the STEL. |
SECTION IV First Aid Measures |
| This first aid information pertains particularly to the active ingredients and any hazardous ingredients, rather than to the formulated product. As the finished product is a tablet for oral or intrauterine administration to animals, inhalation and ingestion by humans are unlikely to occur or to pose a problem. |
| Ingestion |
Generally not required. If concerned rinse mouth with water, give water to drink and seek medical advice. |
| Eye |
Immediately flush eye(s) with lukewarm water for 20 minutes holding eyelids open.Seek medical advice. |
| Skin |
Generally not required. If concerned wash well with soap and water and seek medical advice. |
| Inhalation |
Generally not required. If concerned move to fresh air and seek medical advice. |
SECTION V Fire Fighting Measures |
| Extinguishing Media |
Foam, dry chemical powder, carbon dioxide, water spray (large fires). As appropriate for surrounding materials. |
| Combustion Hazards |
Toxic fumes may be emitted under fire conditions. |
| Precautions for Firefighters |
Wear breathing apparatus. |
| Hazchem Code |
None allocated |
SECTION VI Accidental Release Measures |
| Emergency Procedures |
Spillage of formulated product from marketed packaging is unlikely to ever be serious, however, in the event of a major spill, protect drains and water courses from contamination. |
| Materials and Methods |
Wear protective clothing (overalls, goggles, gloves and boots) and prevent further spillage. Shovel spillage into labelled containers and dispose after consulting appropriate authorities. |
SECTION VII Handling and Storage |
| Precautions |
Always use good occupational work practices and observe recommendations on the label. Keep exposure to this product to a minimum. Prohibit eating, drinking and smoking in storage and handling areas. Wash hands after handling and remove contaminated clothing and any protective equipment before entering eating areas. |
| Conditions |
Store product in original containers as per label instruction (below 25oC, air conditioning). |
SECTION VIII Exposure Controls and Personal Protection |
| National Exposure Standards |
No exposure standard has been allocated for this mixture or any significant ingredient within this mixture. |
| Biological Limit Values |
No biological limit has been allocated for this mixture. |
| Engineering Controls |
No specific engineering controls are required for this mixture. |
| Personal Protective Equipment |
| Eye |
Eye protection is not normally necessary. If concerned wear protective goggles or glasses. |
| Skin |
Skin protection is not normally necessary, however it is good practice to avoid contact with chemicals by wearing suitable gloves when handling. |
| Respiratory |
Protection from inhalation is not normally necessary. If ventilation is inadequate or dust is likely to build up then use of a suitable dust mask would be appropriate. |
SECTION IX Physical and Chemical Properties |
| Appearance |
Round beige quarter scored tablets. |
| Odour |
Typical penicillin odour. |
| pH |
|
| Vapour pressure |
|
| Boiling point/range |
No data available. |
| Freezing/Melting point |
No data available. |
| Solubility |
No data available. |
| Specific gravity/density |
No data available. |
| Flash Points |
No data available. |
| Flammable limits (in air) |
No data available. |
| Ignition temperature |
No data available. |
SECTION X Stability and Reactivity |
| Chemical stability |
This mixture is stable under normal ambient and anticipated storage and handling conditions of temperature and pressure. |
| Conditions to avoid |
Avoid excessive humidity and keep under 25oC. |
| Incompatible materials |
Oxidising agents. |
| Decomposition products |
Amoxycillin trihydrate (active ingredient) can emit toxic fumes under fire conditions.
|
| Hazardous reactions |
Hazardous polymerisation will not occur with amoxycillin. |
SECTION XI Toxicological Information |
| Handling of the formulated product is not expected to cause any adverse affects. The following data pertains particularly to the active and any hazardous ingredients in the formulation, rather than this specific formulation. |
| Acute Health Effects |
|
| Ingestion |
|
| Eye |
Eye contact is not a great risk as this product is a tablet. The data available suggests that this product may cause a transient irritation that is unlikely to be anything more than mildly uncomfortable. This effect should disappear when the product is removed. |
| Skin |
Skin contact is not a great risk as this product is a tablet. The data available suggests that this product is not harmful. Allergic skin reactions may develop in sensitive individuals. |
| Inhalation |
Inhalation is not a great risk as this product is a tablet. The data available suggests that this product will not harm the respiratory system if inhaled. Allergic reactions can result in sensitive individuals following inhalation. |
| Chronic Health Effects |
|
| Ingestion |
Repeated ingestion of penicillin products may cause vomiting and or nausea, diarrhoea, sore and dry throat, sore and black hairy tongue. Some bacterial may develop resistance to this antibiotic with chronic exposure and there is risk of superinfection due to overgrowth of non-susceptible organisms. |
| Eye |
There is no data available on the long term effects of eye contamination with this product. |
| Skin |
The data available suggests that chronic skin contact may lead to sensitisation. |
| Inhalation |
The data available suggests that chronic inhalation may lead to sensitisation. |
| Advice to Doctor |
Treatment for any adverse effects should be symptomatic. Amoxycillin is widely distributed in body fluids and tissues including pleural, pericardial, peritoneal and synovial fluid. It also crosses the placenta. The blood brain barrier is only significantly crossed in the presence of inflammation. Skin reactions usually spontaneously resolve within a few days of withdrawal of amoxycillin. Antihistamines with or without corticosteroids may alleviate symptoms. If serious analphylactoid reactions occur, treatment including adrenalin, oxygen, intravenous corticosteroids and endotracheal intubation may be required. |
| Carcinogenicity |
No ingredient in this formulation is known to be carcinogenic. |
| Compounding effects |
Amoxycillin is secreted in breast milk. |
SECTION XII Ecological Information |
| Ecotoxicity |
No data available. |
| Persistence and Degradability |
No data available. |
| Mobility |
No data available. |
SECTION XIII Disposal Considerations |
| Disposal Methods |
Empty containers may be recycled or sent to a commercial waste disposal site. Unused product should be suitable for landfill however contact the relevant local Waste Disposal Authority. |
| Special Precautions |
|
SECTION XIV Transport Information |
| UN Number |
|
| UN Shipping Name |
None allocated. |
| ADG Class |
None allocated |
| Packing Group |
None allocated. |
| Special Precautions |
None allocated. |
| Hazchem Code |
None allocated |
SECTION XV Regulatory Information |
| Poisons Schedule |
S4 |
SECTION XVI Other Information |
| Date |
This MSDS has been reviewed and updated as required in May 2009. |
| |
|
| Key to Abbreviations |
|
| NOHSC: National Occupational Health and Safety Commission |
| ADG Class: Australian Dangerous Goods Class |
| CAS Number: Chemical Abstracts Service Number |
| TWA: Time Weighted Average |
| STEL: Short Term Exposure Limit |
| UN: United Nations |
| |
| Disclaimer |
| This Material Safety Data Sheet has been developed according
to WORKSAFE Australia, NOHSC Guidelines. Hazard Classifications have been
determined in consultation with the Approved Criteria for Classifying
Hazardous Substances [NOHSC:1008(1999)]. However, to the best of our knowledge,
the finished product is unlikely to cause harm to humans handling, administering
and dispensing as per label instructions. The data, information and recommendations
herein are represented in good faith and are believed to be correct as
of the date hereof. The purpose of this Material Safety Data Sheet is
to describe products in terms of their safety requirements. Apex Laboratories
Pty Ltd make no representation of merchantability, fitness for a particular
purpose or application, or of any other nature with respect to the information
or the product to which the information refers ("the product").
The information is supplied upon the condition that the persons receiving
same will make their own determination as to its suitability prior to
use of the product. The physical data shown herein are typical values
based on material tested. These values should not be construed as guaranteed
analysis of any specific lot or as guaranteed specification for the product
or specific lots hereof. Due care should be taken to make sure that the
use or disposal of this product and/or its packaging is in compliance
with relevant Federal, State and Local Government Regulations. |